ISRG - Intuitive Surgical Inc Stock Analysis

Intuitive Surgical Inc (ISRG) is a publicly traded company listed on the NASD. It operates in the Medical Instruments & Supplies industry, part of the broader Healthcare sector. The company has a market capitalization of 201.58B, generates annual revenue of 9.61B, and reports net income of 2.75B. As of the latest data, the stock is trading at 568.63 USD.

From a valuation and risk perspective, the stock presents the following profile: The stock is trading at a high valuation compared to the market average, suggesting investor optimism or growth expectations. The PEG ratio is above 2, which could imply the stock is overvalued based on its growth outlook. The company has very low leverage, which may indicate conservative financial management or underutilization of debt. This stock does not currently pay a dividend. The stock exhibits higher volatility than the market, which may indicate greater risk and potential reward.

Analyst recommendation stands at Hold (3.9), indicating current market sentiment. Institutional ownership is reported at 85.73%, reflecting confidence from large investors. Over the last 12 months, the stock has shown a performance of 4.75%, trading within a 52-week range of 425.00 - 616.00.

ISRG - Intuitive Surgical Inc

568.63
Analyst Consensus
Hold 3.9
ISRG – Analyst Rating Summary
Analyst Pie Chart
  • Strong Buy: 11
  • Buy: 15
  • Hold: 13
  • Sell: 1
  • Strong Sell: 0
  • Total Analysts:  40

Last update: 2025-12-05 04:25:36
Index: NDX, S&P 500 P/E: 75.27 EPS (ttm): 7.55 Insider Own: 0.62% Shs Outstand: 354.90M Perf Week: -0.98%
Market Cap: 201.58B Forward P/E: 58.68 EPS next Y: 9.69 Insider Trans: -6.60% Shs Float: 352.31M Perf Month: 5.53%
Income(ttm): 2.75B PEG: 5.03 EPS next Q: 2.25 Inst Own: 85.73% Short Float: 2.12% Perf Quarter: 21.80%
Revenue(ttm): 9.61B P/S: 20.97 EPS this Y: 17.89% Inst Trans: -1.75% Short Ratio: 3.17 Perf Half Y: 1.89%
Book/sh: 47.70 P/B: 11.92 EPS next Y: 11.98% ROA: 14.81% Short Interest: 7.45M Perf Year: 4.75%
Cash/sh: 13.85 P/C: 41.06 EPS next 5Y: 14.95% ROE: 16.90% 52W Range: 425.00 - 616.00 Perf YTD: 8.94%
Dividend Est.: - P/FCF: 88.75 EPS past 3/5Y: 11.25% 10.77% ROIC: 16.23% 52W High: 616.00 -7.69% Beta: 1.67
Dividend TTM: - Quick Ratio: 3.74 Sales past 3/5Y: 13.51% 13.27% Gross Margin: 66.37% 52W Low: 425.00 33.80% Perf 5Y: 133.74%
Dividend Ex-Date: - Current Ratio: 4.73 EPS Y/Y TTM: 21.37% Oper. Margin: 29.30% RSI (14): 60.59 Volatility: 1.43% 2.33%
Employees: 15638 Debt/Eq: 0.00 Sales Y/Y TTM: 22.18% Profit Margin: 28.58% Recom: 2.00 Target Price: 604.00
Option/Short: Yes / Yes LT Debt/Eq: 0.00 EPS Q/Q: 24.96% Payout: 0.00% Rel Volume: 0.49 Prev Close: 569.71
Sales Surprise: 4.10% EPS Surprise: 20.31% Sales Q/Q: 22.91% Earnings: Oct 21 AMC Avg Volume: 2.35M Price: 568.63
SMA20: 0.78% SMA50: 10.80% SMA200: 11.75% Undervalued: 6.22%
Volume: 1,147,479 Change: -0.19%
Graham's revised valuation formula
Discounted cash flow (DCF) model
Margin of safety

About Intuitive Surgical Inc

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.

Copyright © 2024 - 2025 www.stocks-expert.com All Rights Reserved.